IRADIMED CORP - Common (IRMD)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common
Shares outstanding
12,602,265
Total 13F shares
4,085,698
Share change
+394,546
Total reported value
$87,134,189
Price per share
$21.35
Number of holders
68
Value change
+$8,149,558
Number of buys
28
Number of sells
31

Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q1 2020

As of 31 Mar 2020, IRADIMED CORP - Common (IRMD) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,085,698 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., Russell Investments Group, Ltd., Nine Ten Capital Management LLC, Ranger Investment Management, L.P., Soleus Capital Management, L.P., RK Capital Management, LLC, Mondrian Investment Partners LTD, and Parkman Healthcare Partners LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.